Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

Healthcare
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > XRX will DELIST from Nasdaq, IMMINENT as per NY NN Financier
View:
Post by SpaceLabs on Dec 04, 2021 5:52pm

XRX will DELIST from Nasdaq, IMMINENT as per NY NN Financier

$1/shr is coming sooner and a DELISTING on NASDAQ.
Dr. Allen D'DOOF after 1/12 RB has no BACKING from the CROOKED Financiers in IPO, REALITY is now knocking on XRX's DOOR STEPS.

Daily it FALLS by 15cents, December has 31 days, figure the share price ABN42/ Boiler Room mates.
Comment by ACTIONK on Dec 05, 2021 1:48pm
Here is a good read for everyone:  https://www.griproom.com/fun/10-signs-your-stock-is-being-manipulated Enjoy and your welcome....
Comment by Anklebiter42 on Dec 05, 2021 4:21pm
Spacechicken definitely fulfills the requirements of Point #2. 
Comment by oneeno on Dec 06, 2021 2:25pm
LOL spacechicken choker is definitly #2
XORTX Therapeutics Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities